Great buying opp for the patient investor. Here we have an innovative tech, with regulatory clearance in Canada and currently being commercialized at 2 clinics (with 3 more expected this year). US FDA already acknowledged the device's use has no AE's, they merely didn't see a justification in the metrics from the trials. Which seems crazy given that patients in Canada literally asked to meet the company to thank them personally for this life-changing product.
News 
Market Data 
Discover 
